Characteristic | Study participants (n = 100) |
---|---|
Age (in years) | |
Mean ± SD | 40.2 ± 8.0 |
Range | 26–64 |
Gendera | |
Males | 30 (30%) |
Females | 70 (70%) |
Marital statusa | |
Married | 52 (52%) |
Unmarried | 48 (48%) |
Occupationa | |
Skilled | 12 (12%) |
Unskilled | 69 (69%) |
Unemployed | 19 (19%) |
Region of origina | |
North west | 46 (46%) |
South west | 41 (41%) |
Others | 13 (13%) |
WHO clinical staginga | |
Stage 1 | 5 (5%) |
Stage 2 | 36 (36%) |
Stage 3 | 52 (52%) |
Stage 4 | 7 (7%) |
Duration of HIV infection (months) | |
Median (IQR) | 68 (42–84) |
Range | 12–168 |
Duration of ART use (months) | |
Median (IQR) | 60 (36–72) |
Range | 12–132 |
CD4 cell count | |
Median (IQR) | 476 (361–619) |
Range | 49–977 |
Current opportunistic infectionsa | |
Tuberculosis | 1 (1%) |
Previous opportunistic infectionsa | |
Tuberculosis | 20 (20%) |
Herpes zoster | 12 (12%) |
Oral candidiasis | 4 (4%) |
Toxoplasmosis | 1 (1%) |